Loading viewer...
investor_presentation
Format: PDF investor_presentation
Publicly-traded closed-end management investment company generating high current income and capital appreciation through investment in equity and junior debt tranches of CLOs. Presents quarterly financial statistics including net investment income, portfolio holdings, and net asset value as of June 30, 2016.
presentation
investor_presentation
26 Pages
Concord Biotech Limited